Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Astria Therapeutics Inc

ATXS
6,19
-0,23 (-3,58%)
07 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202515:46BWAstria Therapeutics beginnt Phase-3-Zulassungsstudie..
28/2/202513:48BWAstria Therapeutics lance l’essai pivot de phase 3..
28/2/202513:33BWアストリア・セラピューティクス、遺伝性血管性浮腫(HAE)治療向けナベニバートの第3相ピボタル試験ALPHA-ORBITを開始
27/2/202514:00BWAstria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal..
25/2/202514:00BWAstria Therapeutics to Present at Upcoming TD Cowen 45th..
20/2/202514:00BWAstria Therapeutics to Present at Upcoming American Academy..
15/2/202500:13EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202521:45EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
04/2/202522:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
04/2/202514:00BWAstria Therapeutics to Present at Upcoming Oppenheimer 35th..
03/2/202514:00BWAstria Therapeutics to Present at Upcoming Western Society..
23/1/202514:00BWAstria Therapeutics Announces Initiation of Phase 1a Trial..
13/1/202514:09EDGAR2Form 8-K - Current report
13/1/202514:00BWAstria Therapeutics Announces Design of ALPHA-ORBIT Pivotal..
03/1/202522:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
19/12/202422:05EDGAR2Form 8-K - Current report
11/12/202414:00BWAstria Therapeutics Announces Positive Final Results from..
03/12/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
14/11/202423:45EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202418:03EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202422:21EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:10BWAstria Therapeutics Reports Third Quarter 2024 Financial..
13/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202414:00BWAstria Therapeutics to Present at Upcoming Jefferies London..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/10/202413:00BWAstria Therapeutics to Present at Upcoming Canadian Society..
21/10/202414:00BWAstria Therapeutics to Present at Upcoming American College..
16/10/202414:00BWEuropean Commission Grants Orphan Medicinal Product..
02/10/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/9/202414:00BWAstria Therapeutics Receives FDA Orphan Drug Designation for..
27/9/202414:00BWAstria Therapeutics to Present at Upcoming Global Angioedema..
19/9/202414:00BWAstria Therapeutics to Present at Upcoming European Academy..
04/9/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/8/202414:00BWAstria Therapeutics to Present at Upcoming Bradykinin..
29/8/202414:00BWAstria Therapeutics to Participate in Upcoming Morgan..
12/8/202422:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202422:10BWAstria Therapeutics Reports Second Quarter 2024 Financial..
12/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:00BWAstria Therapeutics Chooses Ypsomed’s YpsoMate as the..
07/8/202414:00BWAstria Therapeutics to Participate in Upcoming 2024 Wedbush..
02/8/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
02/7/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
06/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 8-K - Current report
04/6/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
Apertura: 6,395 Min: 6,17 Max: 6,46
Chiusura: 6,42

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network